368 related articles for article (PubMed ID: 23725973)
1. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
[TBL] [Abstract][Full Text] [Related]
2. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
[TBL] [Abstract][Full Text] [Related]
3. A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience.
Rago C; Lombardi T; Di Fulvio G; Di Liberato L; Arduini A; Divino-Filho JC; Bonomini M
Toxins (Basel); 2021 Feb; 13(3):. PubMed ID: 33668249
[TBL] [Abstract][Full Text] [Related]
4. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
5. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
[TBL] [Abstract][Full Text] [Related]
7. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
8. L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.
Di Liberato L; Arduini A; Rossi C; Di Castelnuovo A; Posari C; Sacchetta P; Urbani A; Bonomini M
J Nephrol; 2014 Dec; 27(6):699-706. PubMed ID: 24599831
[TBL] [Abstract][Full Text] [Related]
9. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
10. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
11. Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial.
Yan H; Fang W; Lin A; Cao L; Ni Z; Qian J
Am J Kidney Dis; 2017 Apr; 69(4):506-513. PubMed ID: 27751610
[TBL] [Abstract][Full Text] [Related]
12. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
13. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).
de Moraes TP; Andreoli MC; Canziani ME; da Silva DR; Caramori JC; Ponce D; Cassi HV; de Andrade Bastos K; Rio DR; Pinto SW; Filho SR; de Campos LG; Olandoski M; Divino-Filho JC; Pecoits-Filho R
Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
[TBL] [Abstract][Full Text] [Related]
15. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
[TBL] [Abstract][Full Text] [Related]
16. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
Maurer O; Saxenhofer H; Jaeger P; Casez JP; Descoeudres C; Horber FF
Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
[TBL] [Abstract][Full Text] [Related]
17. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
Arfeen S; Goodship TH; Kirkwood A; Ward MK
Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
[TBL] [Abstract][Full Text] [Related]
18. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
19. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
20. [L-carnitine in peritoneal dialysis].
De Vecchi AF; Arduini A; Di Liberato L; Bonomini M
G Ital Nefrol; 2011; 28(4):393-400. PubMed ID: 21809308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]